- Read more: Covid-19, global solidarity, and the case for equitable vaccine distribution through technology transfers
The Covid-19 pandemic has highlighted the importance of health technologies to mitigate against the spread of the disease, but it has also demonstrated that the current biopharmaceutical business model, based on patented medicines and other technologies, leads to vast inequalities in healthcare particularly in low- and middle-income countries. We believe that the pharmaceutical industry has…
- Read more: Publicly-funded research in the era of Big Deals Publishers and Data Surveillance
The products of publicly-funded research are largely in the hands of commercial publishers. The oligopolistic publishers have increased subscription fees and/or article-processing charges (APCs) at rates much higher than inflation, which has implications for information access, global justice of knowledge production, as well as preservation of scholarly records.



